<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00200928</url>
  </required_header>
  <id_info>
    <org_study_id>3.2.93.96.2</org_study_id>
    <nct_id>NCT00200928</nct_id>
  </id_info>
  <brief_title>Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.</brief_title>
  <official_title>Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Netherlands Asthma Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Netherlands Asthma Foundation</source>
  <brief_summary>
    <textblock>
      The degree of TH1-skewing by mycobacteria is controlles by NRAMP1 gene polymorphisms and
      related to the degree of inhibition of TH2-mediated disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomised single blinded intervention study in high-risk newborns vaccinated at the age of
      6 weeks with BCG or placebo.

      Inclusion: high-risk was defined as either a mother or a father and a sibling with present or
      past atopic disease.

      Exclusion: maternal infection in the last week of pregnancy, the use of immunomodulatory
      drugs or antibiotics during pregnancy (mother), the use of antibiotics directly post-partum
      (newborn)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1999</start_date>
  <completion_date>July 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence and severity of atopic disease.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>SCORAD, lung function, IgE, cytokine production by PBMNC's, NRAMP-polymorphisms.</measure>
  </secondary_outcome>
  <enrollment>120</enrollment>
  <condition>Food Allergy</condition>
  <condition>Atopic Dermatitis</condition>
  <condition>Asthma</condition>
  <condition>Rhinitis</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>BCG</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        high-risk was defined as either a mother or a father plus a sibling with present or past
        atopic disease.

        Exclusion Criteria:

        maternal infection in the last week of pregnancy, the use of immunomodulatory drugs or
        antibiotics during pregnancy (mother) or directly post partum (newborn)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maarten O Hoekstra, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilhelmina Children's Hospital Utrecht (UMCU)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wilhelmina Children's Hospital (UMCU)</name>
      <address>
        <city>Utrecht</city>
        <zip>3508AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.kinderallergologie.nl/</url>
    <description>click for more information: Indiaan onderzoek</description>
  </link>
  <verification_date>April 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>April 3, 2006</last_update_submitted>
  <last_update_submitted_qc>April 3, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2006</last_update_posted>
  <keyword>prospective</keyword>
  <keyword>randomised</keyword>
  <keyword>intervention</keyword>
  <keyword>BCG</keyword>
  <keyword>atopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

